WCM Investment Management LLC Has $10.53 Million Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY)

WCM Investment Management LLC lessened its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 512,057 shares of the company's stock after selling 10,027 shares during the period. WCM Investment Management LLC owned about 0.40% of Surgery Partners worth $10,533,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of SGRY. Empowered Funds LLC bought a new stake in shares of Surgery Partners in the 4th quarter worth approximately $245,000. E. Ohman J or Asset Management AB increased its position in shares of Surgery Partners by 40.3% during the 4th quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company's stock valued at $26,317,000 after purchasing an additional 357,023 shares during the period. KBC Group NV increased its position in shares of Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after purchasing an additional 1,577 shares during the period. Inspire Investing LLC increased its position in shares of Surgery Partners by 47.5% during the 4th quarter. Inspire Investing LLC now owns 19,034 shares of the company's stock valued at $403,000 after purchasing an additional 6,131 shares during the period. Finally, Harbor Capital Advisors Inc. increased its position in shares of Surgery Partners by 25.2% during the 4th quarter. Harbor Capital Advisors Inc. now owns 67,443 shares of the company's stock valued at $1,428,000 after purchasing an additional 13,588 shares during the period.

Surgery Partners Stock Up 1.7 %

Shares of NASDAQ:SGRY traded up $0.44 on Thursday, reaching $25.79. The company had a trading volume of 685,428 shares, compared to its average volume of 1,541,284. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $35.29. The stock has a 50-day moving average price of $21.99 and a 200 day moving average price of $26.84. The stock has a market capitalization of $3.28 billion, a P/E ratio of -53.73, a P/E/G ratio of 17.77 and a beta of 2.60. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same period in the prior year, the firm posted $0.15 EPS. Surgery Partners's revenue for the quarter was up 14.3% on a year-over-year basis. On average, equities analysts expect that Surgery Partners, Inc. will post 0.71 EPS for the current year.

Analysts Set New Price Targets

SGRY has been the subject of several research reports. Bank of America assumed coverage on Surgery Partners in a research note on Monday, December 16th. They set a "buy" rating and a $30.00 price objective for the company. JPMorgan Chase & Co. lowered their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research note on Tuesday, December 3rd. Royal Bank of Canada lowered their target price on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 20th. Finally, Macquarie restated an "outperform" rating and issued a $34.00 target price on shares of Surgery Partners in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $36.56.

Insider Buying and Selling

In related news, insider Harrison R. Bane sold 56,315 shares of the business's stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the completion of the transaction, the insider now owns 107,037 shares of the company's stock, valued at approximately $2,744,428.68. The trade was a 34.47 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO David T. Doherty sold 13,641 shares of the business's stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the transaction, the chief financial officer now directly owns 108,862 shares of the company's stock, valued at $2,787,955.82. This represents a 11.14 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 96,733 shares of company stock valued at $2,480,106. Insiders own 2.30% of the company's stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.